Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?

被引:50
作者
Kolibianakis, EM [1 ]
Zikopoulos, K [1 ]
Verpoest, W [1 ]
Camus, M [1 ]
Joris, H [1 ]
Van Steirteghem, AC [1 ]
Devroey, P [1 ]
机构
[1] Free Univ Brussels, Ctr Reprod Med, B-1090 Brussels, Belgium
关键词
blastocyst transfer; day; 3; transfer; GnRH antagonists; ongoing pregnancy rate; recombinant FSH;
D O I
10.1093/humrep/deh447
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The aim of this study was to compare ongoing pregnancy rates per started cycle between patients randomized at consultation to have embryo transfer either on day 3 or on day 5 of in-vitro culture. Methods: All patients <43 years of age for whom IVF was indicated were allowed to participate in the study (day 3 group, 234 patients; day 5 group, 226 patients). Ovarian stimulation was performed either using GnRH antagonists/recombinant FSH (rFSH) (day 3, 70.1% of patients; day 5, 72.6% of patients) or using the long GnRH agonist protocol/urinary gonadotropins (day 3, 29.9% of patients; day 5 27.4% of patients). Results: The random decision to initiate a cycle leading to day 5 as compared with a day 3 transfer was associated with a significantly lower chance of embryo cryopreservation (day 3, 61.5%; day 5, 50.4%; P<0.02). Ongoing pregnancy rate per started cycle did not differ between the two groups compared [day 3, 32.1%, 95% confidence interval (CI) 26.4-38.2%; day 5, 33.2%, 95% CI 27.3-39.5%]. Conclusions: Advising patients at consultation to initiate an IVF cycle leading to a day 5 as compared with a day 3 transfer does not appear to increase the probability of ongoing pregnancy, and is associated with a significantly lower probability of obtaining cryopreserved embryos.
引用
收藏
页码:2550 / 2554
页数:5
相关论文
共 25 条
[1]   Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro [J].
Alikani, M ;
Calderon, G ;
Tomkin, G ;
Garrisi, J ;
Kokot, M ;
Cohen, J .
HUMAN REPRODUCTION, 2000, 15 (12) :2634-2643
[2]   The merits of blastocyst versus cleavage stage embryo transfer: a Cochrane review (vol 19, pg 795, 2004) [J].
Blake, DA ;
Proctor, M ;
Johnson, NP .
HUMAN REPRODUCTION, 2004, 19 (09) :2174-2174
[3]   HUMAN-GENE EXPRESSION 1ST OCCURS BETWEEN THE 4-CELL AND 8-CELL STAGES OF PREIMPLANTATION DEVELOPMENT [J].
BRAUDE, P ;
BOLTON, V ;
MOORE, S .
NATURE, 1988, 332 (6163) :459-461
[4]   Day 5 versus day 3 embryo transfer: a controlled randomized trial [J].
Coskun, S ;
Hollanders, J ;
Al-Hassan, S ;
Al-Sufyan, H ;
Al-Mayman, H ;
Jaroudi, K .
HUMAN REPRODUCTION, 2000, 15 (09) :1947-1952
[5]   Monozygotic twins and transfer at the blastocyst stage after ICSI [J].
da Costa, ALE ;
Abdelmassih, S ;
de Oliveira, FG ;
Abdelmassih, V ;
Abdelmassih, R ;
Nagy, ZP ;
Balmaceda, JP .
HUMAN REPRODUCTION, 2001, 16 (02) :333-336
[6]   In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injection [J].
De Vos, A ;
Van de Velde, H ;
Joris, H ;
Van Steirteghem, A .
HUMAN REPRODUCTION, 1999, 14 (07) :1859-1863
[7]   A review of ten years experience of ICSI [J].
Devroey, P ;
Van Steirteghem, A .
HUMAN REPRODUCTION UPDATE, 2004, 10 (01) :19-28
[8]   A RANDOMIZED, ASSESSOR-BLIND, GROUP-COMPARATIVE EFFICACY STUDY TO COMPARE THE EFFECTS OF NORMEGON(R) AND METRODIN(R) IN INFERTILE FEMALE-PATIENTS UNDERGOING IN-VITRO FERTILIZATION [J].
DEVROEY, P ;
TJANDRAPRAWIRA, K ;
MANNAERTS, B ;
BENNINK, HC ;
SMITZ, J ;
BONDUELLE, M ;
DEBRABANTER, A ;
VANSTEIRTEGHEM, AC .
HUMAN REPRODUCTION, 1995, 10 (02) :332-337
[9]  
Gardner D.K., 1999, REPROD CERTAINTY INF, P377
[10]   A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization [J].
Gardner, DK ;
Schoolcraft, WB ;
Wagley, L ;
Schlenker, T ;
Stevens, J ;
Hesla, J .
HUMAN REPRODUCTION, 1998, 13 (12) :3434-3440